FDA
- Status: approved
usage oral angiogenesis inhibitor (usage oral angiogenesis inhibitor) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Radboud University Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.